Question

I am a breastfeeding mother and i want to know if it is safe to use CRA 032765? Is CRA 032765 safe for nursing mother and child? Does CRA 032765 extracts into breast milk? Does CRA 032765 has any long term or short term side effects on infants? Can CRA 032765 influence milk supply or can CRA 032765 decrease milk supply in lactating mothers?

Answer by DrLact: About CRA 032765 usage in lactation

No information is available on the clinical use of CRA 032765 during breastfeeding. Because CRA 032765 is more than 97% bound to plasma proteins, the amount in milk is likely to be low. The manufacturer recommends that breastfeeding be discontinued during CRA 032765 therapy.

Alternate Drugs

Vincristine(Dangerous)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Thioguanine(Dangerous)
Tamoxifen(Dangerous)
Nilotinib(Unsafe)
Mitoxantrone(Dangerous)
Trastuzumab(Unsafe)
Docetaxel(Dangerous)
Hydroxyurea(Low Risk)
Dactinomycin(Dangerous)
Etoposide(Dangerous)
Nivolumab(Unsafe)
Ipilimumab(Unsafe)
Doxorubicin(Dangerous)
Vinblastine(Dangerous)
Imatinib(Unsafe)
Cladribine(Dangerous)
Gemcitabine(Dangerous)
Cetuximab(Unsafe)
Cyclophosphamide(Dangerous)
Bleomycin(Dangerous)
Carboplatin(Dangerous)
Cisplatin(Unsafe)
Vinorelbine(Dangerous)
Paclitaxel(Dangerous)
Busulfan(Dangerous)
Fluorouracil(Dangerous)
Dacarbazine(Dangerous)
Letrozole(Dangerous)
Alemtuzumab(Low Risk)
Exemestane(Dangerous)
Dasatinib(Unsafe)
Rituximab(Low Risk)
Bevacizumab(Low Risk)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Gemcitabine(Dangerous)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Nilotinib(Unsafe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.